Male dosing
Not establishedNo validated clinical regimen for this product
MGMT RESEARCHPRODUCT CONCEPT
REGENERATIVE & REPAIR RESEARCH
PITLANE-157 10 mg
BPC-157 · Synthetic pentadecapeptide
BPC-157 is one of the most studied repair peptides in modern research. A synthetic 15-amino-acid sequence derived from a protective compound in gastric juice, it shows consistent results across animal studies for tendon, ligament, muscle, bone, and GI tissue repair through angiogenesis, collagen organization, and inflammation control.
$70.00 CADPer vial · 10 mg
01 / COMPOUND PROFILESynthetic pentadecapeptide
02 / QUALITYCOA pending
03 / FULFILLMENTToronto dispatch
04 / FORMATLyophilized powder
Female dosing
Not establishedNo validated clinical regimen for this product
Research frequency
Protocol-dependentDefined by the laboratory research method
Research format
Preclinical researchCell and animal tissue-repair models
Vial quantity
10 mgSingle vial option · $60 CAD
Batch testing
COA pendingSideChain Analytics · Mississauga, Ontario
DESCRIPTION
What is PITLANE-157 10 mg?
PITLANE-157 is our name for BPC-157.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice (Body Protection Compound). It is widely studied in preclinical models for its pro-healing and tissue-protective properties.
Each vial contains 10 mg of labelled lyophilized compound.
BENEFITS / RESEARCH INTERESTTissue protection.
Tissue protection.
Repair pathways.
Key ways it appears to mimic or amplify natural gastrointestinal and tissue repair mechanisms observed in animal studies:
- Strongly upregulates angiogenesis through multiple pathways (VEGF, EGR-1, FAK-paxillin) in injured tissues, similar to the body’s own response during normal wound healing and tendon/ligament repair.
- Accelerates actin reorganization and fibroblast migration, reproducing the cellular behavior seen during physiological recovery from muscle, tendon, ligament, and gut lesions.
- Exerts potent anti-inflammatory effects in the gut and CNS by modulating nitric oxide pathways and reducing pro-inflammatory cytokines, closely resembling the protective actions of the native gastric peptide in response to mucosal injury.
- Promotes tendon-to-bone healing and collagen organization in rat models at levels comparable to or exceeding the body’s natural regenerative processes after injury.
- Demonstrates marked gastroprotective and ulcer-healing activity in rodent models of IBD, NSAID damage, and fistula formation, mirroring the protective role of the parent protein in human gastric juice.
Key takeaway: BPC-157 does not replace mechanical loading, physical therapy, or surgical intervention like natural healing does over time, but in preclinical rodent studies it consistently reproduces or enhances many of the core molecular and cellular signals the body uses during tissue protection and repair.
SCIENTIFIC LITERATUREBPC-157 research
BPC-157 research
& references.
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Review of rodent models showing BPC-157’s consistent positive effects on healing traumatic and systemic injuries in tendons, ligaments, and skeletal muscle, with potential for hypovascular tissues. All studies to date (up to 2019) report prompt healing without carriers needed.
PubMed – 30915550 ↗Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
In rat tendon fibroblasts, BPC-157 dose- and time-dependently increased growth hormone receptor expression, boosting cell proliferation (via MTT assay and PCNA) when combined with growth hormone, supporting tendon healing.
PubMed – 25415472 ↗Product specifications & handling +
- Product
- PITLANE-157 · BPC-157
- Vial quantity
- 10 mg
- Price
- $70.00 CAD per vial
- Form
- Lyophilized powder
- Compound type
- Synthetic pentadecapeptide · 15 amino acids
- Testing
- COA pending · SideChain Analytics
- Dispatch
- Toronto, Ontario
Follow batch-specific supplier instructions and your laboratory’s validated storage and reconstitution procedures.
COA pending. Purity and net-content results will be published when the batch-specific report is available.
MIX EASYYour mixture.
Your mixture.
Made clear.
Select your compound, vial amount, diluent volume, and sample amount. Our calculator converts your inputs into a concentration, volume, and U-100 syringe marking.
01
Set your mixture
mg
mL
Enter an example amount to calculate its volume.
02
Your measurement
PITLANE-157
20units
0.2 mL of solution per sample
U-100 scale1 mL = 100 units
Concentration10 mg/mL
Full samples per vial5
THE CALCULATION
2 mg ÷ 10 mg/mL = 0.2 mL
How to read this calculator +
Concentration = vial amount ÷ solution volume. Sample volume = sample amount ÷ concentration. U-100 scale units = volume in mL × 100; these are volume markings, not units of compound potency.
This example assumes the final solution volume equals the diluent volume entered, and that the compound dissolves completely. It does not establish solubility, compatibility, stability, or an administration dose.
Decimal measurements are mathematical results and may fall between markings. Full samples are rounded down; they do not account for handling losses.
The calculator checks concentration mathematics. It does not select a treatment dose or establish compatibility, sterility, or stability. SEMARO is temporarily unavailable and is omitted from this selector. BAC Water is the diluent, not a peptide.
SIDE EFFECTS & CONSIDERATIONSPreclinical findings.
Preclinical findings.
Product-specific context.
The descriptions and references on this page concern preclinical research. They do not establish a human safety profile or therapeutic regimen for PITLANE-157.
- Review the lot-specific COA when available.
- Identity, purity and net-content testing are separate from sterility and endotoxin testing.
- Use the handling, concentration and exposure conditions defined by your laboratory protocol.
DOSAGE GUIDELINES / LABORATORY CONTEXT
10 mg per vial.
The labelled vial amount is the total compound quantity, not a recommended dose. No validated male or female clinical regimen is established for this product.
Laboratory preparation
Sample amounts, exposure frequency and preparation conditions should follow the validated method for the specific research model.
Use Mix Easy to calculate concentration and sample volume from your laboratory’s inputs.
Open Mix Easy ↗